Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P335 Treatment strategies after mucosal healing (MH) in ulcerative colitis

ECCO'20 Vienna

Year: 2020
Authors:

A. Sitibondo1, A. Viola1, G. Costantino1, A. Centritto1, A. Belvedere1, V. Pisana1, A. Abbruzzese1, A. Alibrandi2, W. Fries1

1Inflammatory Bowel Disease Unit, Department of Clinical and Experimental Medicine, University of Messina, A.O.U. Policlinico ‘G. Martino’, Messina, Italy, 2Department of Economics, University of Messina, Messina, Italy

P336 Minimally invasive surgery is safe and feasible for luminal Crohn’s disease

ECCO'20 Vienna

Year: 2020
Authors:

M. Nnaji, Y.F. Chin, O. Pujji, B. Wilkinson, S. Mohan, N.A. Yassin

Royal Wolverhampton NHS Trust, Colorectal Surgery, Wolverhampton, UK

P337 Usefulness of drug-level monitoring in therapeutic guidance in patients with ulcerative colitis on anti-TNF-α maintenance therapy

ECCO'20 Vienna

Year: 2020
Authors:

E.H. Oh1, Y. A-Ran2, K. Ye-Jee3, K. Jeongseok1, N. Namseok1, P. Sang Hyoung4, Y. Dong-Hoon1, B. Jeong-Sik1, M. Seung-Jae1, Y. Suk-Kyun4, Y. Byong Duk4

1Asan Medical Center, University of Ulsan College of Medicine, Department of Gastroenterology, Seoul, Korea Republic of, 2Asan Medical Center, University of Ulsan College of Medicine, Inflammatory Bowel Disease Center, Seoul, Korea Republic of, 3Asan Medical Center, University of Ulsan College of Medicine, Department of Clinical Epidemiology and Biostatistics, Seoul, Korea Republic of, 4Asan Medical Center, University of Ulsan College of Medicine, Department of Gastroenterology and Inflammatory Bowel Disease Center, Seoul, Korea Republic of

P338 The effectiveness of a standardised biologic care pathway in the management and treatment of inflammatory bowel disease

ECCO'20 Vienna

Year: 2020
Authors:

N. Willett1, C.G. Heisler1, N. Nazer1, B. Currie1, K. Phalen-Kelly1, M. Stewart2, J. Jones2

1Nova Scotia Health Authority, Digestive Care and Endoscopy, Halifax, Canada, 2Dalhousie University, Medicine, Halifax, Canada

P339 Assessment of DNA-thioguanine nucleotide identifies patients at risk of thiopurine-induced leukopoenia in inflammatory bowel disease

ECCO'20 Vienna

Year: 2020
Authors:

X. Zhu1, K. Chao2, X. Gao2, M. Huang1, X.D. Wang1

1School of Pharmaceutical Sciences, Sun Yat-Sen Unversity, Guangzhou, China, 2Department of Gastroenterology, the Sixth Affiliated Hospital- Sun Yat-sen University, Guangzhou, China

P340 Comorbidity is associated with safety outcomes in vedolizumab- and ustekinumab-treated inflammatory bowel disease patientsECCO'20 Vienna
Year: 2020
Authors: V. Asscher1, V. Biemans2,3, M. Pierik3, G. Dijkstra4, A. Van der Meulen-de Jong1, M. Löwenberg5, S. van der Marel6, N. de Boer7, A. Bodelier8, J. Jansen9, R. West10, J. Haans3, W. van Dop2, R. Weersma4, F. Hoentjen2, J. Maljaars1, on behalf of the Dutch Initiative on Crohn and Colitis (ICC)

1Leiden University Medical Center, Department of Gastroenterology and Hepatology, Leiden, The Netherlands, 2Radboud University Medical Centre, Department of Gastroenterology and Hepatology, Nijmegen, The Netherlands, 3Maastricht University Medical Centre, Department of Gastroenterology and Hepatology, Maastricht, The Netherlands, 4University Medical Centre Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands, 5Amsterdam University Medical Centre- Academic Medical Centre, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands, 6Haaglanden Medical Centre, Department of Gastroenterology and Hepatology, Den Haag, The Netherlands, 7Amsterdam University Medical Centre- Vrije Universiteit Amsterdam, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands, 8Amphia Hospital, Department of Gastroenterology and Hepatology, Breda, The Netherlands, 9Onze Lieve Vrouwe Gasthuis, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands, 10Franciscus Gasthuis and Vlietland, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands

P341 Induction of response and remission: a network meta-analysis of induction studies comparing ontamalimab with other treatments for moderate-to-severe ulcerative colitis

ECCO'20 Vienna

Year: 2020
Authors:

A. Vickers1, A. Nag2, B. Devine3, B.E. Sands4, R. Panaccione5, L. Peyrin-Biroulet6, S. Danese7, S. Vermeire8, K.J. Gorelick9, M. Goetsch10, L. Hartley1

1Department of Data Analytics and Design Strategy, RTI Health Solutions, Manchester, UK, 2Outcomes Research and Epidemiology, Shire - a Takeda Company, Health Economics, Lexington, USA, 3School of Pharmacy, University of Washington, Seattle, USA, 4Dr Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai Medical Center, New York, USA, 5Division of Gastroenterology, University of Calgary, Calgary, Canada, 6Department of Gastroenterology, University Hospital of Nancy-Brabois, Vandœuvre-lès-Nancy, France, 7IBD Center, Humanitas University, Milan, Italy, 8Department of Gastroenterology, University Hospital Leuven, Leuven, Belgium, 9Zymo Consulting Group, Clinical Development, Newtown Square, USA, Clinical Development, 10Shire - a Takeda compa#ny, Zug, Switzerland

P342 Diagnostic accuracy of rectal bleeding and stool frequency in predicting mucosal healing in patients with ulcerative colitis in the tofacitinib OCTAVE Phase 3 induction studies

ECCO'20 Vienna

Year: 2020
Authors:

J.F. Colombel1, A.G. Bushmakin2, J.C. Cappelleri2, N. Kulisek3, G.O. Santana4, N. Lawendy3, D. Ponce de Leon5, P.L. Lakatos6

1Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA, 2Pfizer Inc., Groton, CT, USA, 3Pfizer Inc., Collegeville, PA, USA, 4University of the State of Bahia, Salvador, Bahia, Brazil, 5Pfizer Inc., Lima, Peru, Peru, 6McGill University Health Center, Montreal, Québec, Canada

P343 Efficacy of adalimumab in mild-to-moderate inflammatory bowel disease: Real-life data from single-centre experience in the long-term period

ECCO'20 Vienna

Year: 2020
Authors:

F. Akyüz, A. Ormeci, N. Namazova, M. Guzel, A. Abbasgoulizadeh, L. Tahincioğlu, S. Alaskarlı, E. Gürel, E. Bilgin, A. Atasoy, B. Cavus, K. Demir, F. Besısık, S. Kaymakoğlu

Department of Gastroenterology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey

P344 Effectiveness of ustekinumab in refractory Crohn’s disease: A real-life experience in a tertiary referral centre

ECCO'20 Vienna

Year: 2020
Authors:

M. Truyens1,2,3, J. Geldof1, G. Dewitte1, E. Glorieus1, P. Hindryckx1,3, T. Lobaton Ortega1,3

1Department of Gastroenterology, University Hospital Ghent, Ghent, Belgium, 2VIB Center for Inflammation Research, Ghent University, Ghent, Belgium, 3IBD Research Unit, Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium

P345 Lack of anti-TNF drugs levels in fistula tissue: A reason for non-response in Crohn’s perianal fistula?

ECCO'20 Vienna

Year: 2020
Authors:

S. Adegbola1, M. Sarafian2, K. Sahnan1, A. Pechlivanis2, R. Phillips1, C. Knowles3, J. Haddow4, J. Warusavitarne1, O. Faiz1, P. Tozer1, E. Holmes2, A. Hart1

1St. Mark’s Hospital, Department of Colorectal Surgery, Harrow, UK, 2Imperial College London, Computational Systems Division, London, UK, 3Queen Mary University of London, Department of Surgery, London, UK, 4The Blizard Institute- Queen Mary University of London, Department of Surgery, London, UK

P346 Single-centre experience of ustekinumab: Therapeutic drug monitoring in Crohn’s disease patients

ECCO'20 Vienna

Year: 2020
Authors:

C. Liefferinckx1,2, M. Fassin2, D. Thomas3, C. Minsart1,2, A. Cremer1,2, L. Amininejad1, V. Tafciu2, V. Wambacq1, A. Van Gossum1, D. Franchimont1,2

1Department of Gastroenterology, Hôpital Erasme, Brussels, Belgium, 2Laboratory of Experimental Gastroenterology, ULB, Brussels, Belgium, 3Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium

P347 Undetectable levels of adalimumab in clinical practice: Should we say goodbye to the drug?

ECCO'20 Vienna

Year: 2020
Authors:

S. Bejar1, G. Bastida Paz1,2, M. Aguas1,2, A. Garrido Marín1, R. Marques3, E. Valero Pérez1, J. del Hoyo Francisco1, L. Tortosa Seguí1, D. Muñoz Gómez1, J.L. Poveda3, P. Nos Mateu1,2

1Department of Gastroenterology, La Fe University Hospital, Valencia, Spain, 2Enfermedad Inflamatoria Intestinal, Instituto de Investigación Sanitaria La Fe de Valencia IIS La Fe, Valencia, Spain, 3Department of Pharmacy, La Fe University Hospital, Valencia, Spain

P348 Clinical outcomes and response predictors of vedolizumab treatment for anti-TNF-failed patients with IBD in Korea: A prospective multicenter cohort study

ECCO'20 Vienna

Year: 2020
Authors:

J. Kim1, H. Yoon2, K.M. Lee3, S.A. Jung4, D.I. Park5, C.H. Choi6, E.S. Kim7, Y. Jung8, C.S. Eun9, T.O. Kim10, S.B. Kang11, Y.S. Kim12, G.S. Seo13, C.K. Lee14, J.P. Im15, S.J. Park16, J.S. Byeon1, S.J. Myung1, S.K. Yang1, B.D. Ye1

1Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea Republic of, 2Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea Republic of, 3Department of Internal Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea Republic of, 4Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea Republic of, 5Division of Gastroenterology, Department of Internal Medicine, Kangbuk Samsung Hospital- Sungkyunkwan University School of Medicine, Seoul, Korea Republic of, 6Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea Republic of, 7Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea Republic of, 8Division of Gastroenterology, Department of Medicine, Soonchunhyang University College of Medicine, Cheonan, Korea Republic of, 9Department of Internal Medicine, Hanyang University Guri Hospital, Guri, Korea Republic of, 10Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea Republic of, 11Division of Gastroenterology, Department of Internal Medicine, Daejeon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Daejeon, Korea Republic of, 12Department of Internal Medicine, Seoul Paik Hospital, Inje University College of Medicine, Seoul, Korea Republic of, 13Department of Internal Medicine, Wonkwang University School of Medicine, Iksan, Korea Republic of, 14Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Korea Republic of, 15Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea Republic of, 16Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea Republic of

P349 Infliximab in inflammatory bowel disease: Is premedication necessary?

ECCO'20 Vienna

Year: 2020
Authors:

P. Núñez1, C. Figueroa2, L. Flores2, P. Ibáñez2, U. Kronberg3, J. Lubascher2, G. Pizarro2, R. Quera2, D. Simian2

1Gastroenterology Department, San Juan de Dios Hospital, IBD Fellow Clínica Las Condes, Santiago, Chile, 2Clínica Las Condes, Gastroenterology Department, Inflammatory Bowel Disease Program, Santiago, Chile, 3Clínica Las Condes, Surgery Department, Colorectal Unit, Inflammatory Bowel Disease Program, Santiago, Chile

P350 Perceptions of faecal microbiota transplantation in patients with ulcerative colitis

ECCO'20 Vienna

Year: 2020
Authors:

U.K. Chauhan1, J. Popov2, M. Kalantar2, M. Wolfe3, P. Moayyedi3, J.K. Marshall3, S. Halder3, S. Kaasalainen4

1Hamilton Health Sciences, Ambulatory Care Program, Hamilton, Canada, 2College of Medicine and Health, University College Cork, Cork, Ireland, 3Division of Gastroenterology, Department of Medicine, McMaster University, Hamilton, Canada, 4School of Nursing, McMaster University, Hamilton, Canada

P351 Spontaneous intra-abdominal abscesses in Crohn’s disease: The experience of a tertiary centre

ECCO'20 Vienna

Year: 2020
Authors:

T. Pereira Guedes1, P. Sequeira2, L. Freire1, F. Castro-Poças1, A. Rocha3, M. Santos3, I. Pedroto1, P. Lago1

1Department of Gastroenterology, Centro Hospitalar Universitário do Porto, Porto, Portugal, 2Instituto Ciencias Biomédicas Abel Salazar, University of Porto, Porto, Portugal, Department of General Surgery, 3Centro Hospitalar Universitário do Porto, Porto, Portugal

P352 Infliximab-therapy intensification based on endoscopic activity suppresses treatment interruption among patients with Crohn’s disease

ECCO'20 Vienna

Year: 2020
Authors:

Y. Komaki1, S. Kanmura1, K. Yutsudo1, K. Kosuke2, F. Komaki1, A. Tanaka1, N. Nishimata3, Y. Sameshima4, F. Sasaki1, H. Ooi4, K. Tokushige5, Y. Sameshima3, A. Ido1

1Department of Digestive and Lifestyle Diseases, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan, 2Department of Gastroenterology, Kagoshima City Hospital, Kagoshima, Japan, 3Department of Gastroenterology, Sameshima Hospital, Kagoshima, Japan, 4Department of Gastroenterology, Idzuro Imamura Hospital, Kagoshima, Japan, 5Department of Gastroenterology, Kagoshima Kouseiren Hospital, Kagoshima, Japan

P353 Assessing compliance to screening for infectious diseases and vaccination in patients newly diagnosed with inflammatory bowel disease

ECCO'20 Vienna

Year: 2020
Authors:

R. Pringle, A. Assadsangabi

Department of Gastroenterology, Salford Royal Foundation Trust, Manchester, UK

P354 Objectively measured time spent sitting, standing upright, and stepping is associated with disease severity and faecal calprotectin in patients with ulcerative colitis

ECCO'20 Vienna

Year: 2020
Authors:

M. Raman1, J. Vallance2, K. Lyden3, S. Alana4, C. Ohland5, K. McCoy5, S. Kaur1, R. Panaccione1, R. Reimer6, L. Taylor1

1Department of Medicine, University of Calgary, Calgary, Canada, 2Faculty of Health Disciplines, Athabasca University, Athabasca, Canada, 3N/A, KAL Research and Consulting, Denver, USA, 4University of Calgary, Calgary, Canada, 5University of Calgary, Snyder, Calgary, Canada, 6University of Calgary, Department of Kinesiology, Calgary, Canada